menu
    • menu

    Company profile for Solasia Pharma KK

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ‘Sol’ means the Sun and ‘Asia’ the Asian counties in Spanish. We desire to be the Sun brightening the future of various people facing many challenges of cancers in Japan and other Asian countries. We constantly pursue this desire, putting it into the company name ‘Solasia.’ We are passionate to realize as soon as possible and expand ‘what we can do.’ We aspire to respond to unmet medical needs in oncology area ...
    ‘Sol’ means the Sun and ‘Asia’ the Asian counties in Spanish. We desire to be the Sun brightening the future of various people facing many challenges of cancers in Japan and other Asian countries. We constantly pursue this desire, putting it into the company name ‘Solasia.’ We are passionate to realize as soon as possible and expand ‘what we can do.’ We aspire to respond to unmet medical needs in oncology area in Japan and other Asian countries. We head for further leap with more experiences. We strive to produce medicine with efficacy and safety with commitment to improving quality of life for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solasia Pharma KKjapan Flag
    Country
    Country
    Japan
    Address
    Address
    Minato, Tokyo 105-0022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solasia.co.jp/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solasia Announces Launch of Darvias® in Japan
    Solasia Announces Launch of Darvias® in Japan

    22 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220822005303/en

    BUSINESSWIRE
    22 Aug 2022
    Share Share
    Solasia Pharma: DARVIAS Injection 135mg Approved in Japan
    Solasia Pharma: DARVIAS Injection 135mg Approved in Japan

    19 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220620005030/en

    BUSINESSWIRE
    19 Jun 2022
    Share Share
    Announcement of the matters to be resolved at the Ordinary General Meeting
    Announcement of the matters to be resolved at the Ordinary General Meeting

    21 Feb 2022

    // PRESS RELEASE

    https://ssl4.eir-parts.net/doc/4597/tdnet/2088652/00.pdf

    PRESS RELEASE
    21 Feb 2022
    Share Share
    Solasia Announces Finance via Issuance of Unsecured Straight Bond and Warrant
    Solasia Announces Finance via Issuance of Unsecured Straight Bond and Warrant

    14 Feb 2022

    // PRESS RELEASE

    https://ssl4.eir-parts.net/doc/4597/tdnet/2086748/00.pdf

    PRESS RELEASE
    14 Feb 2022
    Share Share
    Business Overview of Pipeline Products
    Business Overview of Pipeline Products

    09 Feb 2022

    // PRESS RELEASE

    https://ssl4.eir-parts.net/doc/4597/tdnet/2080790/00.pdf

    PRESS RELEASE
    09 Feb 2022
    Share Share
    Consolidated Financial Results for the Fiscal Year Ended December 31, 2021
    Consolidated Financial Results for the Fiscal Year Ended December 31, 2021

    09 Feb 2022

    // PRESS RELEASE

    https://ssl4.eir-parts.net/doc/4597/tdnet/2080791/00.pdf

    PRESS RELEASE
    09 Feb 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search